Drugs target to ITGB5

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
CILENGITIDEProteinnoneIntegrin alpha-V/beta-5 antagonist3['Terminated', 'Completed', 'Terminated', 'Completed', 'Completed', 'Unknown status', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Withdrawn', 'Completed', 'Completed', 'Completed', 'Terminated', 'Completed', 'Terminated', 'Completed', 'Terminated', 'Completed', 'Completed', 'Completed', 'Terminated', 'Completed', 'Completed', 'Completed']['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials']